NCT02384018View on ClinicalTrials.gov

Mesenchymal Stem Cell and Islet Co-transplantation

PHASE1CompletedINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

December 31, 2014

Primary Completion Date

June 1, 2016

Study Completion Date

November 21, 2017

Conditions
Chronic PancreatitisDiabetes
Interventions
BIOLOGICAL

autologous mesenchymal stromal cell

Islet transplantation patients will receive autologous MSCs following islets infusion

Trial Locations (1)

29425

GI Surgery, Medical University of South Carolina, Charleston

All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

Medical University of South Carolina

OTHER

NCT02384018 - Mesenchymal Stem Cell and Islet Co-transplantation | Biotech Hunter | Biotech Hunter